Not provided
Not provided
Not provided
Not provided
Futility
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| TRYG Foundation | OTHER |
| Lundbeck Foundation | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Septic shock is in critically ill patients is a condition associated with a high rate of organ failure and hereto attributable mortality ~45-55% Hypothesis: Mild Induced Hypothermia reduces the mortality of critically ill patients with septic shock by reducing organ metabolism, counteracting on microcirculatory thrombosis, genetically downregulating tissue apoptosis and by reducing bacterial growth rate and toxin production.
Septic shock is an acute life-threatening condition, with great organ damage for every hour. The patients have a high risk of dying and therefore rapid treatment is of crucial importance for survival of the patients.
Septic shock is mainly due to a collapse in the blood circulation (the capillary system) due to blockage by blood cells - a process initiated by substances from the cells of the immune system via activation of coagulation. The normal function of the smallest blood vessels is to transport oxygen, nutrients and drugs to organs and tissues, and lead waste products away. While the offer of oxygen and nutrients to the organs decreases, the consumption of oxygen and nutrients increases due to fever and immune reactions.
When the capillary system collapses, the organs and tissues suffer, and various forms of cell death in the organs begins including "programmed cell death" ("apoptosis"). This leads to organ damage, for example brain damage or kidney damage and ultimately to multiple organ dysfunction which is the direct cause of the patient dies.
Mild induced hypothermia (cooling to 32 0C-34 0C) affects at least 5 core areas in the pathophysiology of septic shock: 1) inhibition of inflammation 2) inhibition of apoptosis ("programmed cell death"), 3) antithrombotic, 4) decreases the metabolism and 5) inhibits bacterial growth and production of toxins.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Mild induced hypothermia | Experimental | Induced hypothermia to 32-34 degrees Celsius (90 - 93 degrees Fahrenheit) |
|
| Fever Respect | No Intervention | Standard of care septic shock therapy according to Surviving Sepsis Campaign guidelines |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mild Induced Hypothermia | Procedure | Induction of hypothermia to a target temperature of 32 - 34 degrees Celsius (90 - 93 degrees Fahrenheit |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mortality | All cause | 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Renal failure | RIFLE criteria (R+I+F) eGFR decrease (ml/min/1.73 m2) eGFR decrease to <60 ml/min/1,73) + derivatives of the above | 30 days |
| Respiratory | Use of Mechanical Ventilation on day 4 No. of days where Mechanical Ventilation is used Delta PaO2/FiO2 ratio until day 4 +Derivatives of the above |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jens Ulrik S Jensen, MD, PhD | CHIP & PERSIMUNE, Rigshospitalet, University of Copenhagen | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cleveland Clinic - Outcomes Research | Cleveland | Ohio | 44195 | United States | ||
| Bispebjerg Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29325753 | Derived | Itenov TS, Johansen ME, Bestle M, Thormar K, Hein L, Gyldensted L, Lindhardt A, Christensen H, Estrup S, Pedersen HP, Harmon M, Soni UK, Perez-Protto S, Wesche N, Skram U, Petersen JA, Mohr T, Waldau T, Poulsen LM, Strange D, Juffermans NP, Sessler DI, Tonnesen E, Moller K, Kristensen DK, Cozzi-Lepri A, Lundgren JD, Jensen JU; Cooling and Surviving Septic Shock (CASS) Trial Collaboration. Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trial. Lancet Respir Med. 2018 Mar;6(3):183-192. doi: 10.1016/S2213-2600(18)30004-3. Epub 2018 Jan 8. | |
| 25466837 |
Not provided
Not provided
The Steering Committee will share data after reviewing study propositions - this to assure quality
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012772 | Shock, Septic |
| D018805 | Sepsis |
| ID | Term |
|---|---|
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D007036 | Hypothermia, Induced |
| D064590 | Cool-Down Exercise |
| ID | Term |
|---|---|
| D017679 | Cryotherapy |
| D013812 | Therapeutics |
| D000096063 | Post-Exercise Recovery Techniques |
| D026741 | Physical Therapy Modalities |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 30 days |
| Circulatory breakdown/Septic Shock | Delta MAP days 1-4 Inotropic Score day 1-4 Achieved discontinuation of inotropics on day 4 | Measure on day 4 |
| Cerebral dysfunction | Delta RASS 1-4 CAM-ICU: Days with positive CAM-ICU within 72 h after awakening MiniMentalState Examination (MMSE) | Day 1-4 |
| Hepatic Failure | Delta Bilirubin 1-4 Fraction of subjects with Bilirubin level >21 micromoles/L on day 4 | Days 1-4 |
| Coagulatory Failure | Delta Platelets day 1-4 Delta INR days 1-4 (and factor 2/7/10) Delta APTT (days 1-4) Total consumption of SAG-M on days 1-10 Occurrence of Severe bleeding (surgery demanding or CT-verified, fresh upper or lower G-I bleeding) Thromboelastography | Until Day 4/10 |
| Duration of clinical infection | Delta C-reactive protein day 1-4 Achieved decrease in CRP >30 % from day 1-4 PCT decrease (Quantitative) day 1-10 | Days 1-4 + 1-30 |
| Number of days Free of Organ failure | Number of days Free of Organ failure until day 30: Need for Mechanical ventilation, need for inotropic, RIFLE criteria positive, positive CAM-ICU days. | 30 days |
| Copenhagen |
| Capital Region |
| 2400 |
| Denmark |
| Jens Ulrik S. Jensen | Copenhagen | Capital Region | DK-2200 | Denmark |
| Gentofte Hospital | Gentofte Municipality | Capital Region | 2900 | Denmark |
| Herlev Hospital | Herlev | Capital Region | 2730 | Denmark |
| Nordsjællands Hospital, Hillerød | Hillerød | Capital Region | 3400 | Denmark |
| Aarhus University Hospital, Skejby | Aarhus | Jutland | 8200 | Denmark |
| Horsens Hospital | Horsens | Jutland | Denmark |
| Køge Hospital | Køge | Region Sealand | 4600 | Denmark |
| Roskilde Hospital | Roskilde | Region Sealand | 4000 | Denmark |
| Academic Medical Center | Amsterdam | Netherlands |
| Derived |
| Johansen ME, Jensen JU, Bestle MH, Ostrowski SR, Thormar K, Christensen H, Pedersen HP, Poulsen L, Mohr T, Kjaer J, Cozzi-Lepri A, Moller K, Tonnesen E, Lundgren JD, Johansson PI. Mild induced hypothermia: effects on sepsis-related coagulopathy--results from a randomized controlled trial. Thromb Res. 2015 Jan;135(1):175-82. doi: 10.1016/j.thromres.2014.10.028. Epub 2014 Nov 5. |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D012769 | Shock |
| D012046 | Rehabilitation |
| D015444 | Exercise |
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |